330 related articles for article (PubMed ID: 17276431)
1. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.
Guido M; Romualdi D; De Marinis L; Porcelli T; Giuliani M; Costantini B; Lanzone A
Fertil Steril; 2007 Jul; 88(1):125-30. PubMed ID: 17276431
[TBL] [Abstract][Full Text] [Related]
2. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
[TBL] [Abstract][Full Text] [Related]
3. Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome.
Guido M; Romualdi D; Giuliani M; Suriano R; Tienforti D; Costantini B; Lanzone A
Fertil Steril; 2005 Nov; 84(5):1470-6. PubMed ID: 16275246
[TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
5. Obesity differentially affects serum levels of androstenedione and testosterone in polycystic ovary syndrome.
Moran C; Renteria JL; Moran S; Herrera J; Gonzalez S; Bermudez JA
Fertil Steril; 2008 Dec; 90(6):2310-7. PubMed ID: 18163993
[TBL] [Abstract][Full Text] [Related]
6. Impaired growth hormone secretion after glucose loading in non-obese women with polycystic ovary syndrome, possibly related to androgen but not insulin and free fatty acids.
Takeuchi T; Tsutsumi O; Taketani Y
Gynecol Endocrinol; 2007; 23(8):468-73. PubMed ID: 17852425
[TBL] [Abstract][Full Text] [Related]
7. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
8. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
Ludwig AK; Goharian LG; Dietze T; Tauchert S; Rudolf S; Diedrich K; Schweiger U; Oltmanns KM
Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
[TBL] [Abstract][Full Text] [Related]
9. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
10. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients.
Alvarez-Castro P; Isidro ML; Garcia-Buela J; Leal-Cerro A; Broglio F; Tassone F; Ghigo E; Dieguez C; Casanueva FF; Cordido F
Clin Endocrinol (Oxf); 2004 Aug; 61(2):250-5. PubMed ID: 15272922
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone and ghrelin secretion in severely obese women before and after bariatric surgery.
Valera Mora ME; Manco M; Capristo E; Guidone C; Iaconelli A; Gniuli D; Rosa G; Calvani M; Mingrone G
Obesity (Silver Spring); 2007 Aug; 15(8):2012-8. PubMed ID: 17712119
[TBL] [Abstract][Full Text] [Related]
12. Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study.
Florakis D; Diamanti-Kandarakis E; Katsikis I; Nassis GP; Karkanaki A; Georgopoulos N; Panidis D
Int J Obes (Lond); 2008 Apr; 32(4):692-9. PubMed ID: 18071341
[TBL] [Abstract][Full Text] [Related]
13. The relationship between metabolic status and levels of adiponectin and ghrelin in lean women with polycystic ovary syndrome.
Bik W; Baranowska-Bik A; Wolinska-Witort E; Chmielowska M; Martynska L; Baranowska B
Gynecol Endocrinol; 2007 Jun; 23(6):325-31. PubMed ID: 17616856
[TBL] [Abstract][Full Text] [Related]
14. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.
Waśko R; Komarowska H; Warenik-Szymankiewicz A; Sowiński J
Horm Metab Res; 2004 Mar; 36(3):170-3. PubMed ID: 15057670
[TBL] [Abstract][Full Text] [Related]
15. Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome.
Romualdi D; Giuliani M; Draisci G; Costantini B; Cristello F; Lanzone A; Guido M
Fertil Steril; 2007 Jul; 88(1):131-8. PubMed ID: 17336978
[TBL] [Abstract][Full Text] [Related]
16. Oral glucose load inhibits circulating ghrelin levels to the same extent in normal and obese children.
Baldelli R; Bellone S; Castellino N; Petri A; Rapa A; Vivenza D; Bellone J; Broglio F; Ghigo E; Bona G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):255-9. PubMed ID: 16487433
[TBL] [Abstract][Full Text] [Related]
17. Plasma metastin levels are negatively correlated with insulin resistance and free androgens in women with polycystic ovary syndrome.
Panidis D; Rousso D; Koliakos G; Kourtis A; Katsikis I; Farmakiotis D; Votsi E; Diamanti-Kandarakis E
Fertil Steril; 2006 Jun; 85(6):1778-83. PubMed ID: 16650418
[TBL] [Abstract][Full Text] [Related]
18. Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
Maciel GA; Soares Júnior JM; Alves da Motta EL; Abi Haidar M; de Lima GR; Baracat EC
Fertil Steril; 2004 Feb; 81(2):355-60. PubMed ID: 14967373
[TBL] [Abstract][Full Text] [Related]
19. [Glucose and lipid metabolism in patients with polycystic ovary syndrome].
Ge XL; Lou SZ; Shen HM
Zhonghua Fu Chan Ke Za Zhi; 1994 Sep; 29(9):527-30, 573. PubMed ID: 7835128
[TBL] [Abstract][Full Text] [Related]
20. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]